loadpatents
name:-0.054927825927734
name:-0.59891700744629
name:-0.0040299892425537
Morrison; Sherie L. Patent Filings

Morrison; Sherie L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Morrison; Sherie L..The latest application filed is for "anti-cspg4 fusions with interferon for the treatment of malignancy".

Company Profile
3.21.24
  • Morrison; Sherie L. - Los Angeles CA
  • Morrison; Sherie L. - Scarsdale NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities
Grant 10,975,158 - Morrison April 13, 2
2021-04-13
Anti-CSPG4 fusions with interferon for the treatment of malignancy
Grant 10,822,427 - Morrison , et al. November 3, 2
2020-11-03
Anti-cspg4 Fusions With Interferon For The Treatment Of Malignancy
App 20190135939 - Morrison; Sherie L. ;   et al.
2019-05-09
Targeted interferons demonstrate potent apoptotic and anti-tumor activities
Grant 10,182,984 - Morrison , et al. Ja
2019-01-22
Anti-CSPG4 fusions with interferon for the treatment of malignancy
Grant 10,093,745 - Morrison , et al. October 9, 2
2018-10-09
Cd138-targeted Interferon Demonstrates Potent Apoptotic And Anti-tumor Activities
App 20180162948 - Morrison; Sherie L.
2018-06-14
CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities
Grant 9,803,021 - Morrison October 31, 2
2017-10-31
Targeted Interferons Demonstrate Potent Apoptotic And Anti-tumor Activities
App 20170151342 - MORRISON; SHERIE L. ;   et al.
2017-06-01
Antibody-endostatin fusion protein and its variants
Grant 9,611,313 - Shin , et al. April 4, 2
2017-04-04
Targeted interferons demonstrating potent apoptotic and anti-tumor activities
Grant 9,534,033 - Morrison , et al. January 3, 2
2017-01-03
Anti-cspg4 Fusions With Interferon For The Treatment Of Malignancy
App 20160115242 - Morrison; Sherie L. ;   et al.
2016-04-28
Cd138-targeted Interferon Demonstrates Potent Apoptotic And Anti-tumor Activities
App 20160115239 - Morrison; Sherie L.
2016-04-28
Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities
Grant 9,139,634 - Morrison , et al. September 22, 2
2015-09-22
Antibody- Endostatin Fusion Protein And Its Variants
App 20140220016 - Shin; Seung-Uon ;   et al.
2014-08-07
Targeted Interferons Demonstrate Potent Apoptotic And Anti-tumor Activities
App 20140079668 - MORRISON; SHERIE L. ;   et al.
2014-03-20
Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities
Grant 8,563,692 - Morrison , et al. October 22, 2
2013-10-22
Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities
Grant 8,258,263 - Morrison , et al. September 4, 2
2012-09-04
Method For Targeted And Sustained Antiviral Therapy
App 20110165122 - Shahangian; Arash ;   et al.
2011-07-07
Targeted Interferons Demonstrate Potent Apoptotic And Anti-tumor Activities
App 20110104112 - MORRISON; SHERIE L. ;   et al.
2011-05-05
Antibody- Endostatin Fusion Protein And Its Variants
App 20110038865 - Shin; Seung-Uon ;   et al.
2011-02-17
Targeted Interferon Demonstrates Potent Apoptotic And Anti-tumor Activities
App 20100297076 - Morrison; Sherie L. ;   et al.
2010-11-25
Targeted Interferons Demonstrate Potent Apoptotic And Anti-tumor Activities
App 20100172868 - MORRISON; SHERIE L. ;   et al.
2010-07-08
Antibody fusion proteins: effective adjuvants of protein vaccination
Grant 7,736,652 - Penichet , et al. June 15, 2
2010-06-15
Antibody-avidin fusion proteins as cytotoxic drugs
App 20080213890 - Penichet; Manuel L. ;   et al.
2008-09-04
Rh antibody
Grant 7,238,784 - Morrison , et al. July 3, 2
2007-07-03
Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination
App 20070003514 - Penichet; Manuel L. ;   et al.
2007-01-04
Anti-growth factor receptor avidin fusion proteins as universal vectors for drug delivery
App 20050085419 - Morrison, Sherie L. ;   et al.
2005-04-21
Chimeric molecules and methods of use
App 20050008649 - Shin, Seung-Uon ;   et al.
2005-01-13
Fusion proteins for targeted delivery of antimicrobial peptides
App 20040052814 - Shi, Wenyuan ;   et al.
2004-03-18
Antibody fusion proteins: effective adjuvants of protein vaccination
App 20030187225 - Penichet, Manuel L. ;   et al.
2003-10-02
Anti-microbial targeting chimeric pharmaceutical
App 20030143234 - Shi, Wenyuan ;   et al.
2003-07-31
Rh antibody
App 20030143643 - Morrison, Sherie L. ;   et al.
2003-07-31
Antibody-avidin fusion proteins as cytotoxic drugs
App 20030133938 - Penichet, Manuel L. ;   et al.
2003-07-17
Secretory immunoglobulin produced by single cells and methods for making and using same
App 20020127645 - Morrison, Sherie L. ;   et al.
2002-09-12
Method for the treatment and prevention of dental caries
App 20020068066 - Shi, Wenyuan ;   et al.
2002-06-06
Antibodies having modified carbohydrate content and methods of preparation and use
App 20020028486 - Morrison, Sherie L. ;   et al.
2002-03-07
Secretory immunoglobulin produced by single cells and methods for making and using same
Grant 6,300,104 - Morrison , et al. October 9, 2
2001-10-09
Modified immunoglobin molecules and methods for use thereof
Grant 6,284,536 - Morrison , et al. September 4, 2
2001-09-04
Antibodies having modified carbohydrate content and methods of preparation and use
Grant 6,218,149 - Morrison , et al. April 17, 2
2001-04-17
IgE isoforms and methods of use
Grant 6,043,345 - Saxon , et al. March 28, 2
2000-03-28
Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
Grant 5,977,307 - Friden , et al. November 2, 1
1999-11-02
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
Grant 5,807,715 - Morrison , et al. September 15, 1
1998-09-15
Transferrin neuropharmaceutical agent fusion protein
Grant 5,672,683 - Friden , et al. September 30, 1
1997-09-30
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed